Market Potential II-7
Lack of Dosage Standards for Pediatric Patients' Limits
Radiopharmaceutical Efficacy II-7
Unfounded Fears of Radiation Exposure Hinder Growth II-7
Bottlenecks in Developing Markets II-7
Market Share Statistics: In Retrospect II-8
Table 1: Global Market for Medical Diagnostics Imaging
(2003): Percentage Share Breakdown of Value Sales by Leading
Players - GE (Amersham), Schering, Daiichi, Bristol Myers
Squibb, Mallinckrodt, Bracco, Guerbet, and Others (includes
corresponding Graph/Chart) II-8
Table 2: Global Market for Radiopharmaceutical Medical
Diagnostics (2003): Percentage Revenue Market Share of
Leading Players - Amersham, Bristol-Myers Squibb, Tyco/
Mallinckrodt, Inc and Others (includes corresponding
Graph/Chart) II-8
Table 3: Global Market for Radioimmunotherapy Products
(2003): Percentage Share Breakdown of Value Sales of Zevalin
and Bexxar II-8
2. Product Overview II-9
Nuclear Medicine: A Prelude II-9
Radiopharmaceuticals: A Definition II-9
Mechanism of Action II-9
Application of Radiopharmaceuticals II-10
Classification of Radiopharmaceuticals II-10
Diagnostic Radiopharmaceuticals II-10
Commonly Used Diagnostic Radiopharmaceutical Agents II-11
Major Isotopes and their Diagnostic Applications II-11
Advantages II-12
Classification II-13
Fluorodeoxy Glucose (FDG): A Rapidly Growing Diagnostic
Radiopharmaceutical II-13
Molecular Imaging Modalities In Radiopharmaceutical Diagnostics II-13
Planar Imaging II-13
PET: A Prime Growth Driver for FDG II-14
Advantages II-14
Applications of PET II-15
Commonly used Radioisotopes in PET Scans II-15
Major PET Isotopes and their Applications II-15
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |